These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 15728261

  • 1. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
    Eelen G, Verlinden L, Rochel N, Claessens F, De Clercq P, Vandewalle M, Tocchini-Valentini G, Moras D, Bouillon R, Verstuyf A.
    Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
    [Abstract] [Full Text] [Related]

  • 2. Altered Vitamin D receptor-coactivator interactions reflect superagonism of Vitamin D analogs.
    Eelen G, Verlinden L, Van Camp M, Claessens F, De Clercq P, Vandewalle M, Bouillon R, Verstuyf A.
    J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):65-8. PubMed ID: 16039117
    [Abstract] [Full Text] [Related]

  • 3. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L, Verstuyf A, Quack M, Van Camp M, Van Etten E, De Clercq P, Vandewalle M, Carlberg C, Bouillon R.
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [Abstract] [Full Text] [Related]

  • 4. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [Abstract] [Full Text] [Related]

  • 5. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.
    Herdick M, Bury Y, Quack M, Uskokovic MR, Polly P, Carlberg C.
    Mol Pharmacol; 2000 Jun; 57(6):1206-17. PubMed ID: 10825392
    [Abstract] [Full Text] [Related]

  • 6. Vitamin D analogue-specific recruitment of vitamin D receptor coactivators.
    Issa LL, Leong GM, Sutherland RL, Eisman JA.
    J Bone Miner Res; 2002 May; 17(5):879-90. PubMed ID: 12009019
    [Abstract] [Full Text] [Related]

  • 7. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
    Väisänen S, Peräkylä M, Kärkkäinen JI, Uskokovic MR, Carlberg C.
    Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
    [Abstract] [Full Text] [Related]

  • 8. 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure.
    Shimizu M, Miyamoto Y, Takaku H, Matsuo M, Nakabayashi M, Masuno H, Udagawa N, DeLuca HF, Ikura T, Ito N.
    Bioorg Med Chem; 2008 Jul 15; 16(14):6949-64. PubMed ID: 18539034
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 22-Alkyl-20-epi-1alpha,25-dihydroxyvitamin D3 compounds of superagonistic activity: syntheses, biological activities and interaction with the receptor.
    Yamamoto K, Inaba Y, Yoshimoto N, Choi M, DeLuca HF, Yamada S.
    J Med Chem; 2007 Mar 08; 50(5):932-9. PubMed ID: 17298045
    [Abstract] [Full Text] [Related]

  • 12. Biological activity of CD-ring modified 1alpha,25-dihydroxyvitamin D analogues: C-ring and five-membered D-ring analogues.
    Verstuyf A, Verlinden L, van Etten E, Shi L, Wu Y, D'Halleweyn C, Van Haver D, Zhu GD, Chen YJ, Zhou X, Haussler MR, De Clercq P, Vandewalle M, Van Baelen H, Mathieu C, Bouillon R.
    J Bone Miner Res; 2000 Feb 08; 15(2):237-52. PubMed ID: 10703925
    [Abstract] [Full Text] [Related]

  • 13. A unique insertion/substitution in helix H1 of the vitamin D receptor ligand binding domain in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets.
    Malloy PJ, Xu R, Cattani A, Reyes mL, Feldman D.
    J Bone Miner Res; 2004 Jun 08; 19(6):1018-24. PubMed ID: 15190891
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The unique tryptophan residue of the vitamin D receptor is critical for ligand binding and transcriptional activation.
    Solomon C, Macoritto M, Gao XL, White JH, Kremer R.
    J Bone Miner Res; 2001 Jan 08; 16(1):39-45. PubMed ID: 11149488
    [Abstract] [Full Text] [Related]

  • 16. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF, Fitzgerald P, Zou A, Elgort MG, Bischoff ED, Mere L, Mais DE, Bissonnette RP, Heyman RA, Nadzan AM, Reichman M, Allegretto EA.
    Chem Biol; 1999 May 08; 6(5):265-75. PubMed ID: 10322128
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differential recruitment of coactivators to the vitamin D receptor transcriptional complex by 1alpha,25-dihydroxyvitamin D3 analogs.
    Schwinn MK, DeLuca HF.
    Arch Biochem Biophys; 2007 Sep 15; 465(2):443-51. PubMed ID: 17658451
    [Abstract] [Full Text] [Related]

  • 20. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
    Reddy GS, Rao DS, Siu-Caldera ML, Astecker N, Weiskopf A, Vouros P, Sasso GJ, Manchand PS, Uskokovic MR.
    Arch Biochem Biophys; 2000 Nov 15; 383(2):197-205. PubMed ID: 11185554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.